Dividend policy

Hofseth BioCare aims to give its shareholders a competitive rate of return based on the company's earnings. The dividend will be considered in the context of Hofseth BioCare's financial position, loan terms and capital requirements for existing and new projects.

Contact investor relations

James portrett
James Berger
Chief Commercial Officer
+41 79 950 10 34 jb@hofsethbiocare.no
Crawford portrett
Dr. Crawford Currie
Head of Medical R&D
+44 7968 195497 cc@hofsethbiocare.no